Chordia Therapeutics (TSE:190A) ROE % Adjusted to Book Value : -5.47% (As of Aug. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Chordia Therapeutics ROE % Adjusted to Book Value?

Chordia Therapeutics's ROE % for the quarter that ended in Aug. 2024 was -69.44%. Chordia Therapeutics's PB Ratio for the quarter that ended in Aug. 2024 was 12.69. Chordia Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 was -5.47%.

Chordia Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Chordia Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chordia Therapeutics ROE % Adjusted to Book Value Chart

Chordia Therapeutics Annual Data

Trend

Aug21

Aug22

Aug23

Aug24

ROE % Adjusted to Book Value

-3.32

Chordia Therapeutics Quarterly Data
	Aug21	Aug22	May23	Aug23	May24	Aug24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			-	-	-	-	-5.47

Competitive Comparison of Chordia Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Chordia Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chordia Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chordia Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Chordia Therapeutics's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Chordia Therapeutics ROE % Adjusted to Book Value Calculation

Chordia Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Aug. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-42.19%	/	12.69
	=	-3.32%

Chordia Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Aug. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-69.44%	/	12.69
	=	-5.47%

Chordia Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Chordia Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Chordia Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chordia Therapeutics Inc (TSE:190A) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

2-26-1 Muraoka-Higashi, Kanagawa, Fujisawa, JPN, 251-0012

Website

https://www.chordiatherapeutics.com

Chordia Therapeutics Inc is a bio-venture company specializing in cancer research and development. Its mission is to deliver first-in-class cancer drugs to patients. It is a clinical-stage biotech company engaged in researching and developing novel therapies for cancers with high unmet medical needs.

Chordia Therapeutics Headlines

No Headlines